Abiraterone ratiopharm 500 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

abiraterone ratiopharm 500 mg tabletti, kalvopäällysteinen

teva b.v. - abiraterone acetate - tabletti, kalvopäällysteinen - 500 mg - abirateroni

Abiraterone STADA 500 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

abiraterone stada 500 mg tabletti, kalvopäällysteinen

stada arzneimittel ag - abiraterone acetate - tabletti, kalvopäällysteinen - 500 mg - abirateroni

Abiraterone Glenmark 500 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

abiraterone glenmark 500 mg tabletti, kalvopäällysteinen

glenmark arzneimittel gmbh - abiraterone acetate - tabletti, kalvopäällysteinen - 500 mg - abirateroni

Abiraterone Orion 500 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

abiraterone orion 500 mg tabletti, kalvopäällysteinen

orion corporation - abiraterone acetate - tabletti, kalvopäällysteinen - 500 mg - abirateroni

Abiraterone Accord Euroopan unioni - suomi - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - abirateroniasetaatti - prostatiset kasvaimet - endokriinihoito - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Abiraterone Mylan Euroopan unioni - suomi - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - abirateroniasetaatti - prostatiset kasvaimet - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Abiraterone Krka Euroopan unioni - suomi - EMA (European Medicines Agency)

abiraterone krka

krka, d.d., novo mesto - abirateroniasetaatti - prostatiset kasvaimet - endokriinihoito - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

ANDROCUR 50 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

androcur 50 mg tabletti

bayer oy - cyproteroni acetas - tabletti - 50 mg - syproteroni

Vreya 0.035 mg / 2 mg tabletti, päällystetty Suomi - suomi - Fimea (Suomen lääkevirasto)

vreya 0.035 mg / 2 mg tabletti, päällystetty

stragen nordic a/s - cyproterone acetate, ethinylestradiol - tabletti, päällystetty - 0.035 mg / 2 mg - syproteroni ja estrogeeni

Cypretyl 2 mg / 35 mikrog tabletti, päällystetty Suomi - suomi - Fimea (Suomen lääkevirasto)

cypretyl 2 mg / 35 mikrog tabletti, päällystetty

ratiopharm gmbh - cyproterone acetate, ethinylestradiol - tabletti, päällystetty - 2 mg / 35 mikrog - syproteroni ja estrogeeni